This review summarizes important studies regarding Helicobacter pylori therapy published
from April 2019 to April 2020. The main themes that emerge involve studies assessing …

Gastric cancer (GC) is the fourth leading cause of cancer-related death. Its poor prognosis is
attributed to unclear pathogenesis. Currently, the most widely accepted model for …

Background: Helicobacter pylori (H. pylori) infection is an infectious disease with a
prevalence rate of up to 50% worldwide. It can cause indigestion, gastritis, peptic ulcer, and …

Helicobacter pylori Infection is formally recognised as an infectious disease, an entity that is
now included in the International Classification of Diseases 11th Revision. This in principle …

Helicobacter pylori infection is very common in the Spanish population and represents the
main cause of chronic gastritis, peptic ulcer, and gastric cancer. The last iteration of Spanish …

Background Helicobacter pylori eradication in penicillin‐allergic patients is challenging. The
effective regimen is lacking in areas with high antibiotic resistance and tetracycline …

Helicobacter pylori (HP) is a major causative agent of chronic gastritis and peptic ulcer. HP
is also engaged in the development of gastric cancer and gastric mucosa-associated …

Although discovered 40 years ago, Helicobacter pylori infection is still raising diagnostic and
therapeutic problems today. The infection is currently managed based on statements in …

Background Penicillin‐allergic children who are infected with Helicobacter pylori constitute a
relatively common subgroup. We aimed to study the short‐term and long‐term effects of …

The management of Helicobacter pylori infection has to rely on previous local effectiveness
due to the geographical variability of antibiotic resistance. The aim of this study was to …